QuickSTAT, a Kuehne+Nagel company, recognized as Best Cell & Gene Therapy Supplier
Kuehne+Nagel awards
The Awards highlight top bioprocessing and biomanufacturing leaders in the industry
Singapore- QuickSTAT a leading global life science logistics specialist, received two Asia-Pacific Cell & Gene Therapy Excellence Awards (ACGTEA). The first one was for the Best Cell and Gene Therapy Supplier: Cold Chain Logistics, and the second one was for Best Cell and Gene Therapy: Supply Chain Excellence.
The Asia-Pacific Cell & Gene Therapy Excellence Awards (ACGTEA) 2022 recognizes exceptional bioprocessing experts, organizations and technologies that facilitate biomanufacturing excellence at enhanced speed, reduced cost, and superior quality.
"We are so pleased to be recognized by ACGTEA, which affirms our commitment for exceptional service for our clients throughout the world. We are committed to providing innovative and customized logistics solutions to meet the ever-challenging demands of the life science and healthcare community." Cyril Leger, Executive Vice President of QuickSTAT
A subsidiary of Kuehne+Nagel, QuckSTAT provides a full suite of healthcare logistics services for all stages of the pharmaceutical product lifecycle, from research and drug development through to commercialization. It provides superior management of cell and gene therapies, where QuickSTAT’s specialists will ensure proper handling, packaging and storage of the time-and-temperature sensitive products.